Mujtaba Khalil
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Surgical Treatments
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Oncology 12
- Pancreatic and Hepatic Oncology Research 8
- Co-authors
- Selamawit Woldesenbet (60 shared papers)Timothy Michael Pawlik (63 shared papers)Muhammad Musaab Munir (35 shared papers)Muhammad Muntazir Mehdi Khan (36 shared papers)Yutaka Endo (29 shared papers)Erryk Katayama (25 shared papers)Diamantis I. Tsilimigras (14 shared papers)Vívian Resende (9 shared papers)
- Journals
- Annals of Surgical Oncology (29 papers)Journal of Gastrointestinal Surgery (19 papers)Surgery (13 papers)HPB (9 papers)Journal of Surgical Oncology (7 papers)
- Partner nations
- United StatesJapanPakistan
In The Last Decade
Mujtaba Khalil
83 papers receiving 394 citations
Peers
Comparison fields: 5 of 51
- Hepatology 41
- Oncology 53
- Critical Care and Intensive Care Medicine 7
- Surgery 56
- Public Health, Environmental and Occupational Health 35
Countries citing papers authored by Mujtaba Khalil
This map shows the geographic impact of Mujtaba Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mujtaba Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mujtaba Khalil more than expected).
Fields of papers citing papers by Mujtaba Khalil
This network shows the impact of papers produced by Mujtaba Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mujtaba Khalil. The network helps show where Mujtaba Khalil may publish in the future.
Co-authors
The 25 scholars most cited alongside Mujtaba Khalil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 21 | |
| 2 | 2024 | 18 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 16 | |
| 5 | 2024 | 15 | |
| 6 | 2023 | 15 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2024 | 10 | |
| 11 | 2024 | 10 | |
| 12 | 2024 | 9 | |
| 13 | 2024 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2024 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2024 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2024 | 6 |
About Mujtaba Khalil
Mujtaba Khalil is a scholar working on Hepatology, Oncology, Surgery, Public Health, Environmental and Occupational Health and Genetics, having authored 114 papers that have together received 395 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Pancreatic and Hepatic Oncology Research (8 papers), Opioid Use Disorder Treatment (5 papers), Glioma Diagnosis and Treatment (4 papers), Primary Care and Health Outcomes (2 papers), Meningioma and schwannoma management (2 papers) and Enhanced Recovery After Surgery (2 papers). The work is most often cited by research in Hepatology (41 citations), Oncology (53 citations), Critical Care and Intensive Care Medicine (7 citations), Surgery (56 citations) and Public Health, Environmental and Occupational Health (35 citations). Mujtaba Khalil has collaborated with scholars based in United States, Japan and Pakistan. Frequent co-authors include Selamawit Woldesenbet, Timothy Michael Pawlik, Muhammad Musaab Munir, Muhammad Muntazir Mehdi Khan, Yutaka Endo, Erryk Katayama, Diamantis I. Tsilimigras, Vívian Resende, Aslam M. Ejaz and Mary E. Dillhoff. Their work appears in journals such as Annals of Surgical Oncology, Journal of Gastrointestinal Surgery, Surgery, HPB and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.